Media Home | Contact Us

Media Relations Links • About Us • Media Contact • Frequently Asked Questions • Media Site Map CDC News • Press Release Library • Transcripts • MMWR Summaries • B-Roll Footage • Upcoming Events Related Links • Centers at CDC • Data and Statistics • Health Topics A-Z • Image Library • Publications, Software and Other Products • Global Health Odyssey Find your state or local health department HHS News National Health Observances Div. of Media Relations 1600 Clifton Road MS D-14 Atlanta, GA 30333 (404) 639-3286 Fax (404) 639-7394

November 21, 2001/6:00 PM, ET Contact: CDC Media Relations (404) 639-3286 Press Release CDC Update: Connecticut Anthrax Case and Today's Telebriefing Transcript and Audio Clip Connecticut Inhalation Anthrax Case Confirmed CDC has confirmed a case of inhalational anthrax in Connecticut. CDC was contacted by the Connecticut Department of Public Health about a respiratory illness in a 94-year-old female which preliminary tests had indicated to be anthrax. CDC conducted PCR (polymerase chain reaction) testing on specimens from the woman and confirmed anthrax. In addition to confirming the anthrax case, CDC initially sent an assessment team (5 persons) to Connecticut to assist state health department officials. Today, an additional 12 persons from CDC – including environmental health specialists, epidemiologists, EIS officers, and others – will be joining the team in Connecticut. Summary of Local, State, and Federal Confirmed Human Cases and Exposures Case Status Florida NYC NJ D.C. CT Total Confirmed 2 5 5 5 1 18     Cutaneous 0 4 3 0 0       Inhalational 2 1 2 5 1   Suspect 0 3 2 0   5     Cutaneous 0 3 2 0         Inhalational 0 0 0 0     There have been 5 deaths associated with inhalational anthrax. CDC confirmed cases are based on a rigorous case definition, which was published in CDC’s Morbidity and Mortality Weekly Report (MMWR) on October 19, 2001. The MMWR is available on-line at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5041a1.htm. CDC defines a confirmed case of anthrax as 1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests. CDC defines a suspect case as 1) a clinically compatible case of illness without isolation of B. anthracis and no alternative diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or 2) a clinically compatible case of anthrax epidemiologically linked to a confirmed environmental exposure, but without corroborative laboratory evidence of B. anthracis infection. Today’s telebriefing transcript and audio clip The transcript from today’s telebriefing (Minnesota knee surgery deaths) with Drs. Julie Gerberding and Dan Jernigan is available online. Today's briefing was also webcast and the audio clip is also available online. Both transcript and audio clip are accessible from www.cdc.gov/media/transcripts.htm. For the latest update on CDC activities and on-going anthrax investigations visit www.bt.cdc.gov or www.cdc.gov/media.

Media Home Page | Accessibility | Privacy Policy | Contact Us CDC Home | Search | Health Topics A-Z This page last updated November 21, 2001 URL: United States Department of Health and Human Services Centers for Disease Control and Prevention Office of Communication Division of Media Relations